Medisafe 1 Technologies' Presentation on Company New Launched Website

JERUSALEM, November 5, 2010 /PRNewswire-FirstCall/ --

- Demonstration can be Viewed Online at www.Medisafe1.com

Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has uploaded a product presentation on the company's new website.

To view the website and the presentation, visit http://www.Medisafe1.com.

The presentation highlights the need for syringe locking device technology, and illustrates how barcoding technology can help prevent incorrect medications and dosages from being administered to a wrong patient patient.

"Our online presentation appropriately demonstrates the potential harms caused by human errors when incorrect medications are administered in hospitals," said, Jacob Elhadad, CEO of Medisafe 1 Technologies. "The presentation then demonstrates how MediSafe can prevent tragic mistakes from taking place through the implementation of our patented worlds first syringe locking-device technology."

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

    Contact:

    Jacob Elhadad
    CEO
    +972524440000
    [email protected]

SOURCE Medisafe 1 Technologies Corp.